Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252212452 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Les P Jones und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA. Hauptthemen laut MEDLINE: Probenecid, JNK Mitogen-Activated Protein Kinases, Virus Replication. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIH HHS, georgia research alliance.
Abstract (Originalsprache)
We examined the effect of probenecid in regulating the ERK and JNK downstream MAPK pathways affecting respiratory syncytial virus replication.
Background
We have previously shown that probenecid inhibits RSV, influenza virus, and SARS-CoV-2 replication in vitro in preclinical animal models and in humans. In a Phase two randomized, placebo-controlled, single-blind, dose range-finding study using probenecid to treat non-hospitalized patients with symptomatic, mild-to-moderate COVID-19, we previously showed that a 1000 mg twice daily treatment for 5 days reduced the median time to viral clearance from 11 to 7 days, and a 500 mg twice daily treatment for 5 days reduced the time to viral clearance from 11 to 9 days more than the placebo.
Methods
In this study, we sought to determine the mechanism of action of the probenecid inhibition of RSV replication in human respiratory epithelial (A549) cells.
Results
We show that probenecid inhibits the RSV-induced phosphorylation of JNKs and ERKs and the downstream phosphorylation of c-jun, a component of the AP-1 transcription complex needed for virus replication. The inhibition of JNKs by probenecid reversed the repression of transcription factor HNF-4.
Conclusion
The probenecid inhibition of JNK and ERK phosphorylation involves the MAPK pathway that precludes virus replication.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases, University of Georgia, Athens, GA 30602, USA.
- TrippBio, Inc., Jacksonville, FL 32256, USA.
- Department of Chemistry and Biochemistry, Florida Atlantic University, Jupiter, FL 33431, USA.
ORCID-Profile: David E Martin, Ralph A Tripp
Förderung
- NIAID NIH HHS
- NIH HHS
- georgia research alliance
Zitieren
APA
Jones, L. P., Bergeron, H. C., Martin, D. E., Murray, J., Sancilio, F. D., & Tripp, R. A. (2024). Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252212452
Vancouver
Jones LP, Bergeron HC, Martin DE, Murray J, Sancilio FD, Tripp RA. Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252212452
BibTeX
@article{Jones2024,
author = {Jones, Les P and Bergeron, Harrison C and Martin, David E and Murray, Jackelyn and Sancilio, Fred D and Tripp, Ralph A},
title = {Probenecid Inhibits Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase Mitogen-Activated Protein Kinase Pathways in Regulating Respiratory Syncytial Virus Response},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252212452}
}
EUVIMED